Corcept's Justin Gunn reports 12,191-share holding
The notes describe vesting schedules for unvested awards and options, with continued service required for option vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Corcept Therapeutics Inc. reports that President, Corcept Endocrinology Justin Frederick Gunn directly holds 12,191 common shares, including shares underlying unvested restricted stock awards and units. It also lists four direct stock-option positions: 25,000 shares at a $37.9400 exercise price, expiring August 1, 2034; 25,000 at $60.5800, expiring February 28, 2035; and 13,438 and 8,959 at $35.7000, both expiring February 27, 2036. Award vesting is subject to stated requirements, and option vesting is subject to continued service.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Gunn Justin Frederick
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock option (right to buy) F3 | -- | -- | -- |
| holding | Stock option (right to buy) F4 | -- | -- | -- |
| holding | Stock option (right to buy) F5 | -- | -- | -- |
| holding | Stock option (right to buy) F6 | -- | -- | -- |
| holding | Common Stock F1, F2 | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 72,397 contracts (Direct);
Common Stock — 12,191 shares (Direct)
Footnotes (6)
- F1. Includes 141 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 316 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 405 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 103 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- F2. Includes 6,000 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. The shares underlying the restricted stock unit will vest in equal installments on each quarterly anniversary of September 1, 2026 over a four-year period provided the Reporting Person satisfies certain requirements.
- F3. There were originally 50,000 shares subject to the stock option and an aggregate of 25,000 shares have been previously exercised. The shares subject to the stock option vested and became exercisable with respect to 25% of the shares underlying the option on August 1, 2025 with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on August 1, 2028, subject to the Reporting Person's continued service.
- F4. Exercisable ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date.
- F5. There were originally 15,000 shares subject to the stock option and an aggregate of 1,562 shares have been previously exercised. The shares subject to the stock option vested and became exercisable ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date.
- F6. There were originally 10,000 shares subject to the stock option and an aggregate of 1,041 shares have been previously exercised. The shares subject to the stock option vested and became exercisable ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date.
Key Figures
Direct common shares: 12,191 shares
Stock-option shares and exercise price: 25,000 shares at $37.9400 per share
Stock-option shares and exercise price: 25,000 shares at $60.5800 per share
+2 more
5 metrics
Direct common shares
12,191 shares
Reported on October 1, 2026; includes shares underlying unvested restricted stock awards and units.
Stock-option shares and exercise price
25,000 shares at $37.9400 per share
Expiration date: August 1, 2034.
Stock-option shares and exercise price
25,000 shares at $60.5800 per share
Expiration date: February 28, 2035.
Stock-option shares and exercise price
13,438 shares at $35.7000 per share
Expiration date: February 27, 2036.
Stock-option shares and exercise price
8,959 shares at $35.7000 per share
Expiration date: February 27, 2036.
Key Terms
Stock option (right to buy), unvested restricted stock awards, restricted stock unit, vesting ratably
4 terms
Stock option (right to buy) financial
"Stock option (right to buy)"
unvested restricted stock awards financial
"shares underlying unvested restricted stock awards"
restricted stock unit financial
"shares underlying the restricted stock unit"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vesting ratably financial
"vested and became exercisable ratably in equal installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did the CORT officer report?
Justin Frederick Gunn reported options for 25,000 shares at $37.9400, expiring August 1, 2034; 25,000 at $60.5800, expiring February 28, 2035; and 13,438 and 8,959 shares at $35.7000, both expiring February 27, 2036.
How do Justin Frederick Gunn's unvested CORT awards vest?
Awards granted December 1, 2025, March 2, 2026, June 1, 2026, and September 1, 2026 vest in full on each grant's one-year anniversary, subject to certain requirements. The September 1, 2026 restricted stock unit vests in equal quarterly installments over four years, also subject to certain requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
